Please use this identifier to cite or link to this item:
|Title:||Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model|
|Authors:||Selvi, Ruthrotha B.|
Shanmugam, Muthu K.
Ramakrishnan, Gowsica B.
Siveen, Kodappully Sivaraman
Zayed, M. Emam
Alharbi, Sulaiman Ali
Kundu, Tapas Kumar
|Publisher:||Impact Journals LLC|
Selvi, R. B.; Swaminathan, A.; Chatterjee, S.; Shanmugam, M. K.; Li, F.; Ramakrishnan, G. B.; Siveen, K. S.; Chinnathambi, A.; Zayed, M. E.; Alharbi, S. A.; Basha, J.; Bhat, A.; Vasudevan, M.; Dharmarajan, A.; Sethi, G.; Kundu, T. K., Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model. Oncotarget 2015, 6 (41), 43806-43818.
|Abstract:||Chromatin acetylation is attributed with distinct functional relevance with respect to gene expression in normal and diseased conditions thereby leading to a topical interest in the concept of epigenetic modulators and therapy. We report here the identification and characterization of the acetylation inhibitory potential of an important dietary flavonoid, luteolin. Luteolin was found to inhibit p300 acetyltransferase with competitive binding to the acetyl CoA binding site. Luteolin treatment in a xenografted tumor model of head and neck squamous cell carcinoma (HNSCC), led to a dramatic reduction in tumor growth within 4 weeks corresponding to a decrease in histone acetylation. Cells treated with luteolin exhibit cell cycle arrest and decreased cell migration. Luteolin treatment led to an alteration in gene expression and miRNA profile including up-regulation of p53 induced miR-195/215, let7C; potentially translating into a tumor suppressor function. It also led to down regulation of oncomiRNAs such as miR-135a, thereby reflecting global changes in the microRNA network. Furthermore, a direct correlation between the inhibition of histone acetylation and gene expression was established using chromatin immunoprecipitation on promoters of differentially expressed genes. A network of dysregulated genes and miRNAs was mapped along with the gene ontology categories, and the effects of luteolin were observed to be potentially at multiple levels: at the level of gene expression, miRNA expression and miRNA processing.|
|Appears in Collections:||Research Papers (Tapas K. Kundu)|
Files in This Item:
|2.36 MB||Adobe PDF||View/Open Request a copy|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.